Modified cases of chickenpox after varicella vaccination: Correlation of protection with antibody response

Pediatric Infectious Disease Journal

Volumn 11, Issue 1, 1992, Pages 19-22

  White, C Jo ^a   Kuter, Barbara J ^a   Ngai, Angela ^a   Hildebrand, Carol S ^a   Isganitis, Kathryn L ^a   Patterson, Carolyn M ^a   Capra, Angela ^a   Miller, William J ^a   Krah, David L ^a   Provost, Philip J ^a   Ellis, Ronald W ^a   Calandra, Gary B ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Antibody titers; Breakthrough infections; Varicella; Varicella vaccine

Indexed keywords

CHICKENPOX VACCINE; MARKER; VIRUS ANTIBODY;

ADOLESCENT; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; ATTENUATION; CHICKENPOX; CHILD; CLINICAL ARTICLE; DISEASE COURSE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; VACCINATION;

ADOLESCENT; ANTIBODIES, VIRAL; CHICKENPOX; CHICKENPOX VACCINE; CHILD; CHILD, PRESCHOOL; HERPESVIRUS 3, HUMAN; HUMAN; INFANT; VIRAL VACCINES;

EID: 0026504601     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/00006454-199201000-00006     Document Type: Article

References (25)

1. Weibel RE, Neff BJ, Kuter BJ, Guess HA, Rothenberger CA, Fitzgerald AJ. Live attenuated varicella virus vaccine. N Engl J Med 1984;310:1409-15.
2. Arbeter AM, Starr SE, Preblud SR, Shara T, Paciorek PM, Miller DS. Varicella vaccine trials in healthy children: a summary of comparative and follow-up studies. Am Intern Dis Child 1984;138:434-8.
3. Weibel RE, Kuter BJ, Neff BJ, Rothenberger CA, Fitzgerald AJ, Connor KA. Live Oka/Merck varicella vaccine in healthy children. JAMA 1985;254:2435-9.
4. Johnson CE, Rome LP, Stancin T, Kumar ML. Live attenuated vaccine in healthy 12 to 24-month-old children. Pediatrics 1988;81:512-8.
5. White CJ, Kuter BJ, Hildebrand CS, Isganitis KI, Matthews H, Miller WJ. Varicella vaccine (VARIVAX1') in healthy children and adolescents: results from 1987-1989 Clinical Trials. Pediatrics 1991;87:604-10.
6. Kuter BJ, Weibel RE, Guess HA, Matthews H, Morton DH, Neff BJ. Oka/Merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7 year follow-up studies. Vaccine 1991;9:643-7.
7. Takahashi M, Otsuka T, Okuno Y, Asano Y, Yazaki T, Isomura S. Live vaccine used to prevent the spread of varicella in children in hospital. Lancet 1974;2:1288-90.
8. Wasmuth EH, Miller WJ. Sensitive enzyme-linked immunosorbent assay for antibody to varicella-zoster virus using purified VZV glycoprotein antigen. J Med Virol 1990;32:189-93.
9. Provost PJ, Krah DL, Kuter BJ, Morton DH, Schofield TL, Wasmuth EH. et al. Antibody assays suitable for assessing immune responses to live varicella vaccine. Vaccine 1991;9:111-6.
10. Straus SE, Reinhold W, Smith HA, Ruyechan WT, Henderson DK, Blaese RM, et al. Endonuclease analysis of viral DNA from varicella and subsequent zoster infections in the same patient. N Engl J Med 1984;311:1362-4.
11. Schmidt NJ, Lennette EH, Woodie JD, Ho H. Immunofluores-cent staining in the laboratory diagnosis of varicella-zoster virus infections. J Lab Clin Med 1965;66:403-12.
12. Ozaki T, Matsui Y, Asano Y, Okuno T, Yamanishi K, Takahashi M. Study of virus isolation from pharyngeal swabs in children with varicella. Am J Dis Child 1989;143:1448-50.
13. Gelb D, Dohner PE, Gershon AA, Steinberg SP, Waner JL, Takahashi M. Molecular epidemiology of live, attenuated varicella virus vaccine in children with leukemia and in normal adults. J Infect Dis 1987;155:633-40.
14. Mousner JS, Kramer S. Survival analysis. Epidemiology: an introductory test. Philadelphia: Saunders, 1974:329-38.
15. Mantel N. Chi-square tests with one degree of freedom: extensions of the Maantel-Haenszel procedure. J Am Stat Assoc 1963;58:690-700.
16. Weisherg S. Simple linear regression. Applied linear regression. New York: Wiley, 1980:1-26.
17. Pedersen IR, Mordheist CH, Glikmann G, von Magnus A. Subclinical measles infection in vaccinated seropositive individuals in arctic Greenland. Vaccine 1989;7:345-8.
18. Edmonston MB, Addiss DG, McPherson JT, Berg JL, Circo SR, Davis JP. Mild measles and secondary vaccine failure during a sustained outbreak in a highly vaccinated population. JAMA 1990;263:2467-71.
19. Morgan-Capner P. Does rubella reinfection matter? In: Mortimer PP, ed. Public Health Virology. London: Public Health Laboratory Service, 1986:50-62.
20. Best JM, Banstvala JE, Morgan-Capner P, Miller E. Fetal infection after maternal reinfection with rubella: criteria for defining reinfection. Br Med J 1989;299:773-5.
21. Chen RT, Markowitz LE, Albrecht P, Stewart JA, Mofenson LM, Preblud SR, et al. Measles antibody: reevaluation of protective titers. J Infect Dis 1990;162:1036-42.
22. Balfour HH, Kelly JM, Suarez CS, Huessner RC, Englund JA, Crane DD, et al. Acyclovir treatment of varicella in otherwise healthy children. J Pediatr 1990;116:633-9.
23. Ross AH. Modification of chickenpox in family contacts by administration of gamma globulin. N Engl J Med 1962;267:369-76.
24. Stagno S, Whitley RJ. Herpesvirus infection in the neonate and children. In: Holmes KK, Mardh P, Sparling PF, Wiesner PJ, eds. Sexually transmitted diseases. New York: McGraw-Hill, 1990:863-85.
25. Spear PG. Biology of the herpesvirus. In: Holmes KK, Mardh P, Sparling PF, Wiesner PJ, eds. Sexually transmitted diseases. New York: McGraw-Hill, 1990:334-89.